Abo, Analiza .

HRN: 05-27-26  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2025
METRONIDAZOLE 500MG (TAB)
12/28/2025
01/04/2026
PO
500 Mg
TID
Thickly MSAF, S/P NSVD With Repair Of Perineal Laceration
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines